Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2020

19 Nov 2020
Results of Annual General Meeting
19 Nov 2020
Presentation to Annual General Meeting
30 Oct 2020
Report on Activities for the Quarter ended 30 September 2020
30 Oct 2020
Quarterly Report 30 September 2020
15 Oct 2020
BIT225 HIV-1 Immunomodulatory Paper Published
14 Oct 2020
Presentation to Investors
9 Oct 2020
Annual Report and Notice of AGM
7 Sep 2020
Biotron Compounds Show Activity Against SARS-CoV-2 Virus in Preliminary Assays
27 Aug 2020
Year End Accounts and Preliminary Final Report
27 Aug 2020
Appendix 4G and Corporate Governance Statement 2020
29 Jul 2020
Report on Activities for the Quarter ended 30 June 2020
29 Jul 2020
Quarterly Report 30 June 2020
22 Jul 2020
Shareholder Update
17 Jul 2020
Appointment of Chief Medical Officer
6 Jul 2020
BIT225 Reverses HIV Induced Immune Evasion
22 Jun 2020
Biotron to Present Latest BIT225 Data at International AIDS Conference
23 Apr 2020
Report on Activities for the Quarter ended 31 March 2020
23 Apr 2020
Quarterly Report 31 March 2020
19 Mar 2020
R&D Tax Incentive
12 Mar 2020
BIT225 Restores Immune Function in HIV-1 Infections
27 Feb 2020
Half-year Report 31 December 2019
25 Feb 2020
Shareholder Update
6 Feb 2020
Biotron to Test its Compounds Against Coronavirus
31 Jan 2020
Appendix 3B – New Issue Announcement
24 Jan 2020
Quarterly Report 31 December 2019
23 Jan 2020
Biotron Response to ASX Price Query
22 Jan 2020
Appendix 3Y – Change of Director’s Interest Notice

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 30 October 2024 Legal Notices and Privacy